日本疫苗市場報告（按產品類型、治療類型、技術、給藥途徑、患者類型、適應症、配銷通路、最終用戶和地區）2025-2033

2024年日本疫苗市場規模達30億美元。展望未來， IMARC Group預計到2033年市場規模將達到39億美元，2025-2033年期間的成長率（CAGR）為2.88%。多種慢性病的盛行率不斷上升、醫療保險覆蓋範圍不斷擴大以及群眾對疫苗接種重要性的認知不斷提高是推動市場發展的一些關鍵因素。

疫苗是一種含有減毒或去活化形式的病原體或其成分的生物製劑。它可以刺激免疫系統並提供針對特定疾病的免疫力。它經過了嚴格的安全測試，以確保不會對接受者造成重大風險。它有多種形式，包括減毒活疫苗、去活化疫苗、次單位疫苗、mRNA 疫苗和病毒載體疫苗。在儲存和運輸過程中需要嚴格的溫度控制以保持功效。它對於預防多種傳染病非常有效，而且通常比治療疾病更具成本效益。它通常用於嬰兒和兒童，以保護他們免受麻疹、腮腺炎、德國麻疹和百日咳等疾病的侵害。

日本疫苗市場趨勢：

日本老齡人口的不斷增加是刺激預防與年齡相關的疾病的疫苗需求的主要因素之一。此外，多種慢性病的發生率不斷上升，以及大眾對疫苗接種重要性的認知不斷提高，為該國的市場前景提供了良好的前景。此外，該國還擁有完善的分銷網路，有助於確保疫苗覆蓋全民。此外，日本擴大參與疫苗外交，這提升了其國際地位，並為疫苗製造商創造了機會，提高了生產和出口。此外，兒童疫苗接種計劃的擴大，重點是確保兒童接種建議的疫苗，正在加強市場的成長。此外，對疫苗領域研發（R&D）工作的持續投資正在刺激市場成長。同時，與國際組織的合作日益增多，為人們取得各種疫苗提供了便利，並促進了市場成長。除此之外，強而有力的病患教育活動的發展正在傳播有關疫苗益處的重要訊息，進一步提高疫苗接種率。此外，廣泛的醫療保險覆蓋確保了大多數人口能夠負擔得起疫苗。此外，日本作為醫療旅遊目的地的崛起吸引了尋求疫苗接種等醫療服務的遊客。此外，日本強大的流行病學監測系統有助於及時發現疾病爆發和疫苗接種需求，確保快速應對並滿足疫苗需求。此外，日本國內疫苗生產能力的擴大確保了更自力更生和有彈性的供應鏈，減少了對進口的依賴。同時，該國管理當局正在實施各種激勵措施並簡化監管流程，以鼓勵疫苗的開發和生產。這些措施降低了疫苗製造商的進入門檻，促進了市場創新和競爭。

日本疫苗市場區隔：

產品類型洞察：

• 多價疫苗
• 單價疫苗

治療類型洞察：

• 預防疫苗
• 治療性疫苗

技術洞察：

• 結合疫苗
• 去活化疫苗和次單位疫苗
• 減毒活疫苗
• 重組疫苗
• 類毒素疫苗
• 其他

給藥途徑洞察：

• 肌肉注射和皮下注射
• 口服
• 其他

患者類型洞察：

• 兒科
• 成人

指示見解：

• 細菌性疾病
  • 腦膜炎球菌疾病
  • 肺炎球菌疾病
  • 白喉/破傷風/百日咳（DPT）
  • 結核
  • 流感嗜血桿菌（Hib）
  • 傷寒
  • 其他
• 病毒性疾病
  • 肝炎
  • 流感
  • 人類乳突病毒（HPV）
  • 麻疹/腮腺炎/德國麻疹 (MMR)
  • 輪狀病毒
  • 帶狀皰疹
  • 水痘
  • 日本腦炎
  • 風疹
  • 小兒麻痺
  • 狂犬病
  • 登革熱
  • 其他

配銷通路洞察：

• 醫院藥房
• 零售藥局
• 機構銷售
• 其他

最終用戶洞察：

• 醫院
• 診所
• 疫苗接種中心
• 學術和研究機構
• 其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

• 日本疫苗市場目前表現如何？未來幾年將如何表現？
• 新冠疫情對日本疫苗市場有何影響？
• 日本疫苗市場依產品類型分類是怎樣的？
• 日本疫苗市場依治療類型如何分類？
• 日本疫苗市場依技術分類是怎樣的？
• 日本疫苗市場依給藥途徑的分佈如何？
• 日本疫苗市場依患者類型如何分類？
• 日本疫苗市場按適應症的分佈是怎樣的？
• 日本疫苗市場按配銷通路的分佈如何？
• 根據最終用戶，日本疫苗市場的分佈如何？
• 日本疫苗市場的價值鏈分為哪些階段？
• 日本疫苗的關鍵促進因素和挑戰是什麼？
• 日本疫苗市場的結構是怎麼樣的？主要參與者有哪些？
• 日本疫苗市場的競爭程度如何？

本報告回答的關鍵問題：

• 日本疫苗市場目前表現如何？未來幾年將如何表現？
• 新冠疫情對日本疫苗市場有何影響？
• 日本疫苗市場依產品類型分類是怎樣的？
• 日本疫苗市場依治療類型如何分類？
• 日本疫苗市場依技術分類是怎樣的？
• 日本疫苗市場依給藥途徑的分佈如何？
• 日本疫苗市場依患者類型如何分類？
• 日本疫苗市場按適應症的分佈是怎樣的？
• 日本疫苗市場按配銷通路的分佈如何？
• 根據最終用戶，日本疫苗市場的分佈如何？
• 日本疫苗市場的價值鏈分為哪些階段？
• 日本疫苗的關鍵促進因素和挑戰是什麼？
• 日本疫苗市場的結構是怎麼樣的？主要參與者有哪些？
• 日本疫苗市場的競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

• 研究目標
• 利害關係人
• 資料來源
  • 主要來源
  • 次要來源
• 市場評估
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第3章：執行摘要

第4章：日本疫苗市場-簡介

• 概述
• 市場動態
• 產業趨勢
• 競爭情報

第5章：日本疫苗市場格局

• 歷史與當前市場趨勢（2019-2024）
• 市場預測（2025-2033）

第6章：日本疫苗市場-細分：依產品類型

• 多價疫苗
  • 概述
• 單價疫苗
  • 概述

第7章：日本疫苗市場-分類：依治療類型

• 預防疫苗
  • 概述
• 治療性疫苗
  • 概述

第 8 章：日本疫苗市場 - 按技術細分

• 結合疫苗
  • 概述
• 去活化疫苗和次單位疫苗
  • 概述
• 減毒活疫苗
  • 概述
• 重組疫苗
  • 概述
• 類毒素疫苗
  • 概述
• 其他

第9章：日本疫苗市場-分類：依給藥途徑

• 肌肉注射和皮下注射
  • 概述
• 口服
  • 概述
• 其他

第 10 章：日本疫苗市場 - 細分：依病患類型

• 兒科
  • 概述
• 成人
  • 概述

第 11 章：日本疫苗市場 - 細分：按適應症

• 細菌性疾病
  • 概述
  • 市場區隔
    • 腦膜炎球菌疾病
    • 肺炎球菌疾病
    • 白喉/破傷風/百日咳（DPT）
    • 結核
    • 流感嗜血桿菌（Hib）
    • 傷寒
    • 其他
• 病毒性疾病
  • 概述
  • 市場區隔
    • 肝炎
    • 流感
    • 人類乳突病毒（HPV）
    • 麻疹/腮腺炎/德國麻疹 (MMR)
    • 輪狀病毒
    • 帶狀皰疹
    • 水痘
    • 日本腦炎
    • 風疹
    • 小兒麻痺
    • 狂犬病
    • 登革熱
    • 其他

第 12 章：日本疫苗市場 - 細分：按配銷通路

• 醫院藥房
  • 概述
• 零售藥局
  • 概述
• 機構銷售
  • 概述
• 其他
  • 概述

第 13 章：日本疫苗市場 - 細分：按最終用戶

• 醫院
  • 概述
• 診所
  • 概述
• 疫苗接種中心
  • 概述
• 學術和研究機構
  • 概述
• 其他

第 14 章：日本疫苗市場 - 競爭格局

• 概述
• 市場結構
• 市場參與者定位
• 最佳獲勝策略
• 競爭儀錶板
• 公司評估象限

第 15 章：關鍵參與者簡介

• Company A
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company B
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company C
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company D
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company E
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events

第16章：日本疫苗市場-產業分析

• 促進因素、限制因素和機遇
  • 概述
  • 驅動程式
  • 限制
  • 機會
• 波特五力分析
  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅
• 價值鏈分析

第 17 章：附錄

Japan vaccine market size reached USD 3.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2033, exhibiting a growth rate (CAGR) of 2.88% during 2025-2033. The rising prevalence of several chronic diseases, increasing availability of extensive health insurance coverage, and the growing awareness among the masses about the importance of vaccination represent some of the key factors driving the market.

A vaccine is a biological preparation that contains weakened or inactivated forms of pathogens or their components. It is administered to stimulate the immune system and provide immunity against specific diseases. It is rigorously tested for safety to ensure it does not pose significant risks to recipients. It is available in various forms, which include live attenuated, inactivated, subunit, mRNA, and viral vector vaccines. It requires strict temperature control during storage and transportation to maintain efficacy. It is highly effective in preventing a wide range of infectious diseases and often more cost-effective than treating the diseases. It is routinely administered to infants and children to protect them from diseases like measles, mumps, rubella, and pertussis.

Japan Vaccine Market Trends:

The expanding aging population in Japan represents one of the primary factors catalyzing the demand for vaccines to protect against age-related diseases. Additionally, the rising prevalence of several chronic diseases and the growing awareness among the masses about the importance of vaccination are offering a favorable market outlook in the country. Along with this, the country has a well-established distribution network that aids in ensuring vaccines reach the entire population. Apart from this, the increasing participation of Japan in vaccine diplomacy initiatives is bolstering its international standing and creating opportunities for vaccine manufacturers, enhancing production and exports. Furthermore, the expansion of pediatric vaccination programs with a focus on ensuring children receive recommended vaccines is strengthening the growth of the market. Moreover, continuous investments in research and development (R&D) efforts in the field of vaccines are stimulating the market growth. Along with this, rising collaborations with international organizations are facilitating access to a wide range of vaccines and contributing to market growth. Apart from this, the introduction of robust patient education campaigns is disseminating vital information about the benefits of vaccines, further improving acceptance rates. In addition, the availability of extensive health insurance coverage is ensuring the affordability of vaccines for the majority of the population. In addition, the emergence of Japan as a healthcare tourism destination is attracting visitors seeking healthcare services, including vaccinations. Furthermore, the robust epidemiological surveillance systems in Japan facilitate the identification of disease outbreaks and vaccination needs promptly, ensuring a swift response and heightened vaccine demand. Moreover, the expansion of domestic vaccine manufacturing capacity in Japan is ensuring a more self-reliant and resilient supply chain, reducing dependence on imports. Along with this, governing authorities of the country are implementing various incentives and streamlining regulatory processes to encourage vaccine development and manufacturing. These initiatives reduce the barriers to entry for vaccine manufacturers, fostering innovation and competition in the market.

Japan Vaccine Market Segmentation:

Product Type Insights:

• Multivalent Vaccine
• Monovalent Vaccine

Treatment Type Insights:

• Preventive Vaccine
• Therapeutic Vaccine

Technology Insights:

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Others

Route of Administration Insights:

• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others

Patient Type Insights:

• Pediatric
• Adult

Indication Insights:

• Bacterial Diseases
  • Meningococcal Disease
  • Pneumococcal Disease
  • Diphtheria/Tetanus/Pertussis (DPT)
  • Tuberculosis
  • Haemophilus Influenzae (Hib)
  • Typhoid
  • Others
• Viral Diseases
  • Hepatitis
  • Influenza
  • Human Papillomavirus (HPV)
  • Measles/Mumps/Rubella (MMR)
  • Rotavirus
  • Herpes Zoster
  • Varicella
  • Japanese Encephalitis
  • Rubella
  • Polio
  • Rabies
  • Dengue
  • Others

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Institutional Sales
• Others

End User Insights:

• Hospitals
• Clinics
• Vaccination Centers
• Academic and Research Institutes
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan vaccine market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan vaccine market?
• What is the breakup of the Japan vaccine market on the basis of product type?
• What is the breakup of the Japan vaccine market on the basis of treatment type?
• What is the breakup of the Japan vaccine market on the basis of technology?
• What is the breakup of the Japan vaccine market on the basis of route of administration?
• What is the breakup of the Japan vaccine market on the basis of patient type?
• What is the breakup of the Japan vaccine market on the basis of indication?
• What is the breakup of the Japan vaccine market on the basis of distribution channel?
• What is the breakup of the Japan vaccine market on the basis of end user?
• What are the various stages in the value chain of the Japan vaccine market?
• What are the key driving factors and challenges in the Japan vaccine?
• What is the structure of the Japan vaccine market and who are the key players?
• What is the degree of competition in the Japan vaccine market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Vaccine Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Vaccine Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Vaccine Market - Breakup by Product Type

• 6.1 Multivalent Vaccine
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Monovalent Vaccine
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)

7 Japan Vaccine Market - Breakup by Treatment Type

• 7.1 Preventive Vaccine
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Therapeutic Vaccine
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)

8 Japan Vaccine Market - Breakup by Technology

• 8.1 Conjugate Vaccines
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Inactivated and Subunit Vaccines
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Live Attenuated Vaccines
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Recombinant Vaccines
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Toxoid Vaccines
  • 8.5.1 Overview
  • 8.5.2 Historical and Current Market Trends (2019-2024)
  • 8.5.3 Market Forecast (2025-2033)
• 8.6 Others
  • 8.6.1 Historical and Current Market Trends (2019-2024)
  • 8.6.2 Market Forecast (2025-2033)

9 Japan Vaccine Market - Breakup by Route of Administration

• 9.1 Intramuscular and Subcutaneous Administration
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Oral Administration
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)
• 9.3 Others
  • 9.3.1 Historical and Current Market Trends (2019-2024)
  • 9.3.2 Market Forecast (2025-2033)

10 Japan Vaccine Market - Breakup by Patient Type

• 10.1 Pediatric
  • 10.1.1 Overview
  • 10.1.2 Historical and Current Market Trends (2019-2024)
  • 10.1.3 Market Forecast (2025-2033)
• 10.2 Adult
  • 10.2.1 Overview
  • 10.2.2 Historical and Current Market Trends (2019-2024)
  • 10.2.3 Market Forecast (2025-2033)

11 Japan Vaccine Market - Breakup by Indication

• 11.1 Bacterial Diseases
  • 11.1.1 Overview
  • 11.1.2 Historical and Current Market Trends (2019-2024)
  • 11.1.3 Market Segmentation
    • 11.1.3.1 Meningococcal Disease
    • 11.1.3.2 Pneumococcal Disease
    • 11.1.3.3 Diphtheria/Tetanus/Pertussis (DPT)
    • 11.1.3.4 Tuberculosis
    • 11.1.3.5 Haemophilus Influenzae (Hib)
    • 11.1.3.6 Typhoid
    • 11.1.3.7 Others
  • 11.1.4 Market Forecast (2025-2033)
• 11.2 Viral Diseases
  • 11.2.1 Overview
  • 11.2.2 Historical and Current Market Trends (2019-2024)
  • 11.2.3 Market Segmentation
    • 11.2.3.1 Hepatitis
    • 11.2.3.2 Influenza
    • 11.2.3.3 Human Papillomavirus (HPV)
    • 11.2.3.4 Measles/Mumps/Rubella (MMR)
    • 11.2.3.5 Rotavirus
    • 11.2.3.6 Herpes Zoster
    • 11.2.3.7 Varicella
    • 11.2.3.8 Japanese Encephalitis
    • 11.2.3.9 Rubella
    • 11.2.3.10 Polio
    • 11.2.3.11 Rabies
    • 11.2.3.12 Dengue
    • 11.2.3.13 Others
  • 11.2.4 Market Forecast (2025-2033)

12 Japan Vaccine Market - Breakup by Distribution Channel

• 12.1 Hospital Pharmacies
  • 12.1.1 Overview
  • 12.1.2 Historical and Current Market Trends (2019-2024)
  • 12.1.3 Market Forecast (2025-2033)
• 12.2 Retail Pharmacies
  • 12.2.1 Overview
  • 12.2.2 Historical and Current Market Trends (2019-2024)
  • 12.2.3 Market Forecast (2025-2033)
• 12.3 Institutional Sale
  • 12.3.1 Overview
  • 12.3.2 Historical and Current Market Trends (2019-2024)
  • 12.3.3 Market Forecast (2025-2033)
• 12.4 Others
  • 12.4.1 Overview
  • 12.4.2 Historical and Current Market Trends (2019-2024)
  • 12.4.3 Market Forecast (2025-2033)

13 Japan Vaccine Market - Breakup by End User

• 13.1 Hospitals
  • 13.1.1 Overview
  • 13.1.2 Historical and Current Market Trends (2019-2024)
  • 13.1.3 Market Forecast (2025-2033)
• 13.2 Clinics
  • 13.2.1 Overview
  • 13.2.2 Historical and Current Market Trends (2019-2024)
  • 13.2.3 Market Forecast (2025-2033)
• 13.3 Vaccination Centers
  • 13.3.1 Overview
  • 13.3.2 Historical and Current Market Trends (2019-2024)
  • 13.3.3 Market Forecast (2025-2033)
• 13.4 Academic and Research Institutes
  • 13.4.1 Overview
  • 13.4.2 Historical and Current Market Trends (2019-2024)
  • 13.4.3 Market Forecast (2025-2033)
• 13.5 Others
  • 13.5.1 Historical and Current Market Trends (2019-2024)
  • 13.5.2 Market Forecast (2025-2033)

14 Japan Vaccine Market - Competitive Landscape

• 14.1 Overview
• 14.2 Market Structure
• 14.3 Market Player Positioning
• 14.4 Top Winning Strategies
• 14.5 Competitive Dashboard
• 14.6 Company Evaluation Quadrant

15 Profiles of Key Players

• 15.1 Company A
  • 15.1.1 Business Overview
  • 15.1.2 Product Portfolio
  • 15.1.3 Business Strategies
  • 15.1.4 SWOT Analysis
  • 15.1.5 Major News and Events
• 15.2 Company B
  • 15.2.1 Business Overview
  • 15.2.2 Product Portfolio
  • 15.2.3 Business Strategies
  • 15.2.4 SWOT Analysis
  • 15.2.5 Major News and Events
• 15.3 Company C
  • 15.3.1 Business Overview
  • 15.3.2 Product Portfolio
  • 15.3.3 Business Strategies
  • 15.3.4 SWOT Analysis
  • 15.3.5 Major News and Events
• 15.4 Company D
  • 15.4.1 Business Overview
  • 15.4.2 Product Portfolio
  • 15.4.3 Business Strategies
  • 15.4.4 SWOT Analysis
  • 15.4.5 Major News and Events
• 15.5 Company E
  • 15.5.1 Business Overview
  • 15.5.2 Product Portfolio
  • 15.5.3 Business Strategies
  • 15.5.4 SWOT Analysis
  • 15.5.5 Major News and Events

16 Japan Vaccine Market - Industry Analysis

• 16.1 Drivers, Restraints and Opportunities
  • 16.1.1 Overview
  • 16.1.2 Drivers
  • 16.1.3 Restraints
  • 16.1.4 Opportunities
• 16.2 Porters Five Forces Analysis
  • 16.2.1 Overview
  • 16.2.2 Bargaining Power of Buyers
  • 16.2.3 Bargaining Power of Suppliers
  • 16.2.4 Degree of Competition
  • 16.2.5 Threat of New Entrants
  • 16.2.6 Threat of Substitutes
• 16.3 Value Chain Analysis

17 Appendix